The Next Big Vaccination Scam: Norovirus

by Heidi Stevenson

23 January 2010

Just as the truth starts to sneak out to the general public about the swine flu fraud, the powers-that-be are organizing the next great fake pandemic: norovirus, complete with a brand new vaccine. You've likely never heard of it, but you've probably had it several times. It's a mild stomach virus. You get nausea and possibly vomit or have diarrhea. You feel bad for a day or so, and then it's over. No big deal—until now.

Perhaps you've started seeing the headlines about norovirus, also mistakenly dubbed "stomach flu" or "vomiting bug" popping up. Suddenly, it's becoming a big deal. What was considered nothing more than a nuisance "has claimed up to 500,000 victims," according to the Mail Online and "is putting the NHS under massive strain". The chairman of the Royal College of GPs, Dr. Steve Field, says

It seems incredibly serious. We know it peaks twice a year and it looks like we are in the middle of a second serious peak in a few months that could be affecting up to half a million people.

And so it begins—the selling of another mild disease as a monster. Fear is already being built in the hope that people will clamor for a vaccine. The techniques being used are the same as for swine flu. Notice the doctor said that the virus has "claimed up to 500,000 victims". The truth is that the numbers are unknown. The Telegraph says, "Experts believe cases of norovirus could rise further in the coming weeks." It's just like the CDC's fake claims of deaths from swine flu.

Field further stated, "We can only estimate the figures because most cases go unreported." Could it possibly be that the disease isn't worth reporting? News reports talk about wards closing, making it sound like a terrible situation. The reality, though, is that the wards are closed so they can be scrubbed to remove the virus. It's nothing new.

But wait! There isn't a vaccine for it!

But there is, and it's almost ready to be rolled out. LigoCyte Pharmaceuticals is nearly through the testing process for its norovirus vaccine and the marketing has already begun. LigoCyte's Chief Operating Officer will speak at the World Vaccine Congress during its annual meeting in April.

Marketing has already started in the news media. In August, BBC News reported on the LigoCyte vaccine being tested, focusing on the idea that it's "green" because it's developed from plants, instead of eggs.

But surely the government won't push this vaccine after the swine flu fiasco?

In fact, there is evidence that governments will try to ram the novovirus vaccine. The need of the people isn't the issue. The concern is lost time at work. When you consider that the CDC has included vaccination for rotavirus, another gastroenteritis infection of equivalent severity, in its vaccine schedule, it is probably virtually automatic to include a norovirus vaccine when it's available. Recommendations being floated already are for annual vaccinations against norovirus, since it mutates like flu.

At least the vaccine will be effective, won't it?

Thus far, no vaccine has been shown to be effective. A certain, rather arbitrary, level if antibodies is all that's looked for—but how much protection is provided remains unknown. It's known that vaccinated people can come down with the disease, and it's been shown that children with asthma are three times more likely to be hospitalized from influenza when they've been vaccinated.

Even if the norovirus vaccine should prove to be effective in 100% of the people who receive it, that would still protect against only 36% of gastroenteritis cases. According to the LigoCyte's own documentation:

In a large three year ('93-'96) infectious intestinal disease study performed in the U.K. (Eur J Clin Micro Infect Dis 2007; 26(5): 311-23) traditional microscopy and ELISA assays failed to detect an enteric pathogen in 49% of the cases of gastroenteritis, and only 6% of the samples were norovirus positive. Recently, PCR techniques were employed to re-test the 4,000+ original stool samples. Norovirus-positive samples increased to 36% upon re-analysis, with onl

In other words, only 36% of all gastroenteritis cases are caused by norovirus! So, the vaccine will protect you only about one-third of the time.

Will the vaccine at least be safe?

The most upsetting part of this tale is that the norovirus vaccine may be one of the most dangerous yet. The next article will discuss the vaccine itself—how it's made, the ingredients, and the potential risks.